China's vaccine 'successful' in trial after Europe-US

News Desk: The coronavirus vaccine made in China has been successful in the mid-stage trial. Researchers working on the vaccine claim that this is what the British media reported on Wednesday (November 18) in a report in the BBC.

Researchers say the trial involved 600 people. Where the coronavirus vaccine developed by Synovec Biotech has been able to quickly build up immunity. Chinese researchers have announced that more than 90 percent of vaccines made in Europe and the United States have been reported to be effective. Although European-American vaccines have been tested on a large scale.

In that case, the trial run on 700 people is hardly comparable. Meanwhile, the US biotechnology company Mordana, which manufactures the vaccine, claims that the potential vaccine to prevent the epidemic coronavirus is effective in about 95 percent of cases. The news was reported in an online BBC report on Monday (November 18). The vaccine was pushed to 30,000 people in the United States in that last-ditch trial. Half of them were given two doses of the vaccine every 4 weeks.

In addition, the rest are given nominal injections. There was no dose of vaccine in them. The US pharmaceutical company Pfizer and the German biotechnology company Bioentech say the vaccine they developed is 90 percent effective. They claim that tests on the vaccine in 43,500 people in that country have initially yielded such results.